Cargando…

Correlation of preferentially expressed antigen of melanoma (PRAME) gene expression with clinical characteristics in acute leukemia patients

BACKGROUND: Preferentially expressed antigen of melanoma (PRAME) gene is regularly overexpressed in acute leukemia (AL) and other malignant diseases which are recognized by human leucocyte antigen (HLA-24) located in the human chromosome of 22q11 coded by 509 amino acids. To rule out the PRAME gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulkarni, Nagaraj V., Shetty, Reshma A., Kumari N, Suchetha, Shetty, Vijith V., Krishna, Rajesh, Arumugam, Meenakshi, Kalal, Akanksha A., Shetty, Prashanth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256891/ https://www.ncbi.nlm.nih.gov/pubmed/35788450 http://dx.doi.org/10.1186/s43141-022-00376-7

Ejemplares similares

A diagnostic approach to detect cytogenetic heterogeneity and its prognostic significance in multiple myeloma
por: Kalal, Akanksha A., et al.
Publicado: (2023)

Prognostic significance of dysregulation of shelterin complex and its correlation with telomere length and cytogenetics in multiple myeloma
por: Kalal, Akanksha A., et al.
Publicado: (2023)

Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study
por: Cazzato, Gerardo, et al.
Publicado: (2022)

Association of Sperm Aneuploidy Frequency and DNA Fragmentation Index in Infertile Men
por: Arumugam, Meenakshi, et al.
Publicado: (2019)

In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)
por: Pankov, Dmitry, et al.
Publicado: (2017)

Y chromosome microdeletion and cytogenetic findings in male infertility: A cross-sectional descriptive study
por: Arumugam, Meenakshi, et al.
Publicado: (2021)

Breast Carcinoma – A Comparative Study of Immunohistochemistry and Fluorescence in Situ Hybridization for Her-2 Assessment and Association of ER, PR, HER-2 and Ki-67 Expression with Clinico-Pathological Parameters
por: K, Sajitha, et al.
Publicado: (2022)

Medium-Chain Fatty Acids and Breast Cancer Risk by Receptor and Pathological Subtypes
por: Roopashree, Padmanabha Ganeshkodi, et al.
Publicado: (2022)

PReferentially Expressed Antigen in MElanoma (PRAME): preliminary communication on a translational tool able to early detect Oral Malignant Melanoma (OMM)
por: Cascardi, Eliano, et al.
Publicado: (2023)

PRAME expression is similar in scar and desmoplastic melanoma
por: Plotzke, Jaclyn M., et al.
Publicado: (2022)

PRAME Expression in Mucosal Melanoma of the Head and Neck Region
por: Ricci, Costantino, et al.
Publicado: (2023)

Preferentially Expressed Antigen of Melanoma (PRAME) and Wilms’ Tumor 1 (WT 1) Genes Expression in Childhood Acute Lymphoblastic Leukemia, Prognostic Role and Correlation with Survival
por: Khateeb, Engy El, et al.
Publicado: (2014)

Delineating the role of single-nucleotide polymorphism of CYP19 gene on aromatase activity in South Indian women with polycystic ovary syndrome
por: Hegde, Pravesh, et al.
Publicado: (2023)

Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry
por: Sivaccumar, Jwala Priyadarsini, et al.
Publicado: (2021)

Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock
por: Muto, Yusuke, et al.
Publicado: (2020)

PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma
por: Glutsch, Valerie, et al.
Publicado: (2022)

Fatty acids and their role in type-2 diabetes (Review)
por: Shetty, Shilpa S., et al.
Publicado: (2021)

Analyses of Molecular and Histopathologic Features and Expression of PRAME by Immunohistochemistry in Mucosal Melanomas
por: Toyama, Aimi, et al.
Publicado: (2019)

A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors
por: Gérard, Catherine, et al.
Publicado: (2015)

Fatty acid desaturase 2 (FADS 2) rs174575 (C/G) polymorphism, circulating lipid levels and susceptibility to type-2 diabetes mellitus
por: Shetty, Shilpa S., et al.
Publicado: (2021)

Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis
por: Huang, Quan, et al.
Publicado: (2016)

PRAME induces genomic instability in uveal melanoma
por: Kurtenbach, Stefan, et al.
Publicado: (2023)

PRAME expression and clinical outcome of breast cancer
por: Epping, M T, et al.
Publicado: (2008)

Lack of PRAME Expression in Cutaneous T-Cell Lymphomas
por: Bui, Chau M., et al.
Publicado: (2021)

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma
por: Albertsmeier, Markus, et al.
Publicado: (2020)

PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples
por: Ronchi, Andrea, et al.
Publicado: (2022)

Intrinsic disorder in PRAME and its role in uveal melanoma
por: Antonietti, Michael, et al.
Publicado: (2023)

Evaluation of micronutrient status in serum and saliva of oral submucous fibrosis patients: A clinicopathological study
por: Shetty, Shishir Ram, et al.
Publicado: (2012)

Status of salivary lipid peroxidation in oral cancer and precancer
por: Shetty, Shishir Ram, et al.
Publicado: (2014)

Tetraspanin CD9: A friend or foe of head and neck cancer
por: P.C., Suhasini, et al.
Publicado: (2022)

Exploring the differentially expressed genes in human lymphocytes upon response to ionizing radiation: a network biology approach
por: Sekaran, Tamizh Selvan Gnana, et al.
Publicado: (2021)

Environmental pollutants and their effects on human health
por: Shetty, Shilpa S., et al.
Publicado: (2023)

Solitary Fibrous Tumour of Cervical Spinal Cord
por: Koduru, Mallikarjuna Rao, et al.
Publicado: (2020)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

PRAME protein expression in DICER1‐related tumours
por: Thorner, Paul S, et al.
Publicado: (2022)

PRAME protein expression in DICER1‐related tumours
por: Thorner, Paul S, et al.
Publicado: (2022)

Molecular and clinicopathological implications of PRAME expression in adult glioma
por: Le, Minh-Khang, et al.
Publicado: (2023)

Comprehensive Review of Hepatocellular Carcinoma in India: Current Challenges and Future Directions
por: Shetty, Vijith Vittal, et al.
Publicado: (2022)

Correction: Intrinsic disorder in PRAME and its role in uveal melanoma
por: Antonietti, Michael, et al.
Publicado: (2023)

Cytotoxicity Evaluation of Combination Irrigant Regimens with MTAD on Two Different Cell Lines
por: Ravinanthanan, Manikandan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p1snk4714nr2ur1dq6ssuhnjb4